Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice

Biochemical Journal

Volumn 385, Issue 1, 2005, Pages 189-195

  Gautier, Thomas ^a   Masson, David ^a   Jong, Miek C ^b   Pais De Barros, Jean Paul ^a   Duverneuil, Linda ^a   Le Guern, Naig ^a   Deckert, Valérie ^a   Dumont, Laure ^a   Bataille, Amandine ^a   Zak, Zoulika ^a   Jiang, Xian Cheng ^c   Havekes, Louis M ^b,d   Lagrost, Laurent ^a  

^a INSERM   (France)

^b TNO   (Netherlands)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apolipoprotein CI (apoCI); Cholesteryl ester transfer protein (CETP); High density lipoprotein (HDL); Hyperlipidaemia; Transgenic mice

Indexed keywords

BIOCHEMISTRY; CHEMICAL ACTIVATION; ESTERS; GENES; REDUCTION;

ACCUMULATION; APOLIPOPROTEIN CI (APOCI); HIGH-DENSITY LIPOPROTEINS (HDL); MASS CONCENTRATION; MICE;

PROTEINS;

ABC TRANSPORTER; ABC TRANSPORTER G5; APOLIPOPROTEIN C1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL TRANSPORT; GENE OVEREXPRESSION; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 19944434327     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041149     Document Type: Article

References (46)

1. Morton, R. E. and Zilversmit, D. B. (1983) Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258, 11751-11757
2. Bruce, C., Chouinard, Jr, R. A. and Tall, A. R. (1998) Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18, 297-330
3. Herrera, V. L., Makrides, S. C., Xie, H. X., Adari, H., Krauss, R. M., Ryan, U. S. and Ruiz-Opazo, N. (1999) Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat. Med. 5, 1383-1389
4. Hirano, K., Yamashita, S. and Matsuzawa, Y. (2000) Pros and cons of inhibiting cholesteryl ester transfer protein. Curr. Opin. Lipidol. 11, 589-596
5. Sugano, M., Makino, N., Sawada, S., Otsuka, S., Watanabe, M., Okamoto, H., Kamada, M. and Mizushima, A. (1998) Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J. Biol. Chem. 273, 5033-5036
6. Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H., Hammond, R. A., Beattie, D. T. et al. (2000) Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20, 2106-2112
7. Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K. and Shinkai, H. (2000) Cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature (London) 406, 203-207
8. de Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A. and Kastelein, J. J. (2002) Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 105, 2159-2165
9. Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P. and Rader, D. J. (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350, 1505-1515
10. Clark, R. W., Sutfin, T. A., Ruggeri, R. B., Willauer, A. T., Sugarman, E. D., Magnus-Aryitey, G., Cosgrove, P. G., Sand, T. M., Wester, R. T., Williams, J. A. et al. (2004) Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler. Thromb. Vasc. Biol. 24, 490-497
11. Guyard-Dangremont, V., Lagrost, L. and Gambert, P. (1994) Comparative effects of purified apolipoproteins A-I, A-II, and a-IV on cholesteryl ester transfer protein activity. J. Lipid Res. 35, 982-992
12. Lagrost, L., Persegol, L., Lallemant, C. and Gambert, P. (1994) Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer activity - particles containing various proportions of apolipoproteins A-I and A-II. J. Biol. Chem. 269, 3189-3197
13. Kushwaha, R. S., Hasan, S. Q., McGill, Jr, H. C., Getz, G. S., Dunham, R. G. and Kanda, P. (1993) Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboon (Papio sp.). J. Lipid Res. 34, 1285-1297
14. Cho, K. H., Lee, J. Y., Choi, M. S., Cho, J. M., Lim, J. S. and Park, Y. B. (1998) A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 1391, 133-144
15. Connolly, D. T., Krul, E. S., Heuvelman, D. and Glenn, K. C. (1996) Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfate. Biochim. Biophys. Acta 1304, 145-160
16. Wang, X., Driscoll, D. M. and Morton, R. E. (1999) Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F. J. Biol. Chem. 274, 1814-1820
17. Martin, L. J., Connelly, P. W., Nancoo, D., Wood, N., Zhang, Z. J., Maguire, G., Quinet, E., Tall, A. R., Marcel, Y. L. and McPherson, R. (1993) Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E phenotype. J. Lipid Res. 34, 437-446
18. Quinet, E. M., Agellon, L. B., Kroon, P. A., Marcel, Y. L., Lee, Y. C., Whitlock, M. E. and Tall, A. R. (1990) Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J. Clin. Invest. 85, 357-363
19. Pape, M. E., Rehberg, E. F., Marotti, K. R. and Melchior, G. W. (1991) Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels. Arterioscler. Thromb. 11, 1759-1771
20. Quinet, E., Tall, A., Ramakrishnan, R. and Rudel, L. (1991) Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87, 1559-1566
21. Jiang, X. C., Moulin, P., Quinet, E., Goldberg, I. J., Yacoub, L. K., Agellon, L. B., Compton, D., Schnitzer-Polokoff, R. and Tall, A. R. (1991) Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J. Biol. Chem. 266, 4631-4639
22. Jiang, X. C., Agellon, L. B., Walsh, A., Breslow, J. L. and Tall, A. (1992) Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice - dependence on natural flanking sequences. J. Clin. Invest. 90, 1290-1295
23. Masucci-Magoulas, L., Plump, A., Jiang, X. C., Walsh, A., Breslow, J. L. and Tall, A. R. (1996) Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. J. Clin. Invest. 97, 154-161
24. Jong, M. C., Gijbels, M. J., Dahlmans, V. E., Gorp, P. J., Koopman, S. J., Ponec, M., Hofker, M. H. and Havekes, L. M. (1998) Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein CI. J. Clin. Invest. 101, 145-152
25. Shachter, N. S., Ebara, T., Ramakrishnan, R., Steiner, G., Breslow, J. L., Ginsberg, H. N. and Smith, J. D. (1996) Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI. J. Clin. Invest. 98, 846-855
26. Gautier, T., Masson, D., de Barros, J. P., Athias, A., Gambert, P., Aunis, D., Metz-Boutigue, M. H. and Lagrost, L. (2000) Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer activity. J. Biol. Chem. 275, 37504-37509
27. Gautier, T., Masson, D., Jong, M. C., Duverneuil, L., Le Guern, N., Deckert, V., Pais de Barros, J. P., Dumont, L., Bataille, A., Zak, Z. et al. (2002) Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice. J. Biol. Chem. 277, 31354-31363
28. Jong, M. C., Dahlmans, V. E., van Gorp, P. J., van Dijk, K. W., Breuer, M. L., Hofker, M. H. and Havekes, L. M. (1996) In the absence of low density lipoprotein receptor, human apolipoprotein CI overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoprotein via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98, 2259-2267
29. Masson, D., Duverger, N., Emmanuel, F. and Lagrost, L. (1997) Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human apolipoproteins - lack of lipid transfer inhibitory activity in transgenic mice expressing human apo A-I. J. Biol. Chem. 272, 24287-24293
30. Lagrost, L., Gambert, P., Meunier, S., Morgado, P., Desgres, J., d'Athis, P. and Lallemant, C. (1989) Correlation between apolipoprotein A-IV and triglyceride concentration in human sera. J. Lipid Res. 30, 701-710
31. Gandjini, H., Gambert, P., Athias, A. and Lallemant, C. (1991) Resistance to LDL oxidative modifications of an N-terminal apolipoprotein B epitope. Atherosclerosis 89, 83-93
32. Guyard-Dangremont, V., Lagrost, L., Gambert, P. and Lallemant, C. (1994) Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin. Chim. Acta 231, 147-160
33. Lagrost, L., Athias, A., Herbeth, B., Guyard-Dangremont, V., Artur, Y., Paille, F, Gambert, P. and Lallemant, C. (1996) Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins-physiological relevance in alcoholic patients. J. Biol. Chem. 271, 19058-19065
34. Rubin, E. M., Ishida, B. Y., Clift, S. M. and Krauss, R. M. (1991) Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. U.S.A. 88, 434-438
35. Havel, R. J., Fielding, C. J., Olivecrona, T., Shore, V. G., Fielding, P. E. and Egelrud, T. (1973) Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry 12, 1828-1833
36. Jong, M. C., van Dijk, K. W., Dahlmans, V. E., Van der Boom, H., Kobayashi, K., Oka, K., Siest, G., Chan, L., Hofker, M. H. and Havekes, L. M. (1999) Reversal of hyperlipidemia in apolipoprotein CI transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem. J. 338, 281-287
37. Weisgraber, K. H., Mahley, R. W., Kowal, R. C., Herz, J., Goldstein, J. L. and Brown, M. S. (1990) Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265, 22453-22459
38. Swaney, J. B. and Weisgraber, K. H. (1994) Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J. Lipid Res. 35, 134-142
39. Sehayek, E. and Eisenberg, S. (1991) Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266, 18259-18267
40. Mann, C. J., Yen, F. T., Grant, A. M. and Bihain, B. E. (1991) Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88, 2059-2066
41. Bagdade, J. D., Lane, J. T., Subbaiah, P. V., Otto, M. E. and Ritter, M. C. (1993) Accelerated cholesteryl ester transfer in non insulin-dependent diabetes mellitus. Atherosclerosis 104, 69-77
42. Hayek, T., Azrolan, N., Verdery, R. B., Walsh, A., Chajek-Shaul, T., Agellon, L. B., Tall, A. R. and Breslow, J. L. (1993) Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. J. Clin. Invest. 92, 1143-1152
43. Jong, M. C., Hofker, M. H. and Havekes, L. M. (1999) Role of ApoCs in lipoprotein metabolism - functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19, 472-484
44. Luo, Y. and Tall, A. R. (2000) Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. 105, 513-520
45. Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. and Mangelsdorf, D. J. (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277, 18793-18800
46. Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J. M., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L. and Mangelsdorf, D. J. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14, 2819-2830